MovDisordV3, Main, Merge, indexHead, AutAff.i

Author's uniq id: Chase T
Total number of names:
Total number of records with affiliations: 40

T N Chase

NONE	006923 006A20 007057

T. Chase

France INSERM U 289 & Fédération de Neurologie, Hôpital de la Salpêtrière‐47, Bd de l'Hôpital‐75651 Paris, Cedex 13 Cedex 13 Cedex 13	007A19
NONE	007791

T. N. Chase

États-Unis Maryland Experimental Therapeutics Branch, N.I.N.D.S., National Institutes of Health, Bethesda	009343
États-Unis Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland Maryland	007E11
États-Unis NeuroCom International, Clackamas, OR Oregon	009343
Experimental Therapeutics Branch, National Institute of Neurological Diseases and Stroke, National Institutes of HealthBethesda, MarylandUSA1 aut.2 aut.3 aut.4 aut.5 aut.6 aut. États-Unis Maryland	008218
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MarylandUSA1 aut.2 aut.3 aut.4 aut.5 aut. États-Unis Maryland	008909
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MarylandUSA1 aut.3 aut.4 aut. États-Unis Maryland	008045
Experimental Therapeutics Branch, National Institute of Neurological Disorders and StrokeBethesda, MarylandUSA1 aut.2 aut.3 aut. États-Unis Maryland	008209
Experimental Therapeutics Branch, National Institute of Neurological Disorders and StrokeBethesda, MarylandUSA1 aut.2 aut.3 aut.4 aut. États-Unis Maryland	008948
NONE	008E76 008E92 009082 009134 009396 009516 009543 009870

TN Chase

NONE (BIBLIO)

000814

Thomas N. Chase

États-Unis Maryland Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda	009816
États-Unis Experimental Therapeutics Branch National Institute of Neurological Disorders and Stroke Bethesda, Maryland Maryland	008821
États-Unis Experimental Therapeutics Branch, NINDS, National Institutes of Health, Bethesda, Maryland Maryland	009417
États-Unis Experimental Therapeutics Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland Maryland	008005
États-Unis Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland Maryland	007F92 009458
États-Unis Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland Maryland	004730 005024 005688 006C53 007299 007E44
États-Unis National Institutes of Health, NINDS, Bethesda, Maryland Maryland	006B45
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MarylandUSA1 aut.2 aut.3 aut.4 aut.5 aut. États-Unis Maryland	004B76
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MarylandUSA1 aut.2 aut.3 aut.4 aut.5 aut.6 aut. États-Unis Maryland	005A04
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MarylandUSA1 aut.2 aut.3 aut.4 aut.5 aut.6 aut.7 aut. États-Unis Maryland	005341
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesda, MarylandUSA5 aut.6 aut. États-Unis Maryland	006E72
National Institutes of Health, NINDSBethesda, MarylandUSA2 aut.3 aut. États-Unis Maryland	006D83

<g><k>Chase T</k>
<l><g><k>T N Chase</k>
<l><g><k><affiliation>NONE</affiliation>
</k>
<l><i>006923</i>
<i>006A20</i>
<i>007057</i>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>1</n>
<t>3</t>
</g>
<g><k>T. Chase</k>
<l><g><k><affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U 289 & Fédération de Neurologie, Hôpital de la Salpêtrière‐47, Bd de l'Hôpital‐75651 Paris, Cedex 13</wicri:regionArea>
<wicri:noRegion>Cedex 13</wicri:noRegion>
<wicri:noRegion>Cedex 13</wicri:noRegion>
</affiliation>
</k>
<l><i>007A19</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation>NONE</affiliation>
</k>
<l><i>007791</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
<g><k>T. N. Chase</k>
<l><g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Experimental Therapeutics Branch, N.I.N.D.S., National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</k>
<l><i>009343</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>007E11</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>NeuroCom International, Clackamas, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</k>
<l><i>009343</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008218</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008909</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008045</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008209</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008948</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation>NONE</affiliation>
</k>
<l><i>008E76</i>
<i>008E92</i>
<i>009082</i>
<i>009134</i>
<i>009396</i>
<i>009516</i>
<i>009543</i>
<i>009870</i>
</l>
<n>8</n>
<t>8</t>
</g>
</l>
<n>9</n>
<t>16</t>
</g>
<g><k>TN Chase</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000814</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Thomas N. Chase</k>
<l><g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda</wicri:cityArea>
</affiliation>
</k>
<l><i>009816</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Experimental Therapeutics Branch National Institute of Neurological Disorders and Stroke Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008821</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Experimental Therapeutics Branch, NINDS, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>009417</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Experimental Therapeutics Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>008005</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>007F92</i>
<i>009458</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>004730</i>
<i>005024</i>
<i>005688</i>
<i>006C53</i>
<i>007299</i>
<i>007E44</i>
</l>
<n>6</n>
<t>6</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institutes of Health, NINDS, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>006B45</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>004B76</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>005A04</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>005341</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>006E72</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>National Institutes of Health, NINDS</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l><i>006D83</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>12</n>
<t>18</t>
</g>
</l>
<n>5</n>
<t>40</t>
</g>

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)